期刊文献+

反相高效液相测定洛伐他汀方法的改良 被引量:3

Improvement of RT-HPLC on determination of lovastatin
下载PDF
导出
摘要 目的 探索采用反相高效液相色谱法 (HPLC) ,提高检出血浆洛伐他汀浓度及缩短测定时间。方法 HPLC条件 :色谱柱YWG -C1 8(1 0 μm) ;流动相∶甲醇∶水 (83∶1 7,V/V) ;柱温 2 5℃ ;检测波长 2 37nm。血浆经环己烷和异丙醇萃取浓缩后 ,直接进样测定洛伐他汀的浓度。结果 血浆洛伐他汀浓度在 2 0~ 80 0 μg/L范围内线性关系良好 ,回归方程式 ^y =2 4 1 56 +1 97 2 5x(r=0 9991 ) ;最低检测限为 2 0 μg/L ;平均回收率为 (96 0 1± 7 1 7) %。测定一个样品的时间只需 6min。结论 血浆前处理充分 ,流动相甲醇与水比例适当是提高检测限和缩短测定样品时间的关键 。 Objective To improve the detection concentration and time of plasma lovastatin by studying the RP-HPLC method.Methods The condition of HPLC:The analytical column was packed with YWG-C18(10?μm).The mobile phase was methanol-water(83∶17,V/V).The temperature of column was 25?℃.The compounds were quantified using a ultraviolet detector operated at 237?nm?The lovastatin in plasma sample extracted by cycllohexane-isopropyl alcohol.Results The liner range of plasma lovastatin was 2.0-80?ng/ml.The regression recation was =241 56+197 25x( r =0 999?1).The limit of detection was 2 0?μg/L and the mean recovery was (96 01±7 17)%.The determination of a sample only needed 6?min.Conclusion Controlling the pretreatment of plasma and the ratio of methanol to water was the way to enhance the detection limit and shorten detection time.
出处 《中国公共卫生》 CAS CSCD 北大核心 2003年第7期814-815,共2页 Chinese Journal of Public Health
关键词 洛伐他汀 HPLC 方法改良 血浆 lovastatin HPLC method improvement plasma
  • 相关文献

参考文献9

  • 1孙考祥,吴琳华,胡君茹,黄海燕,田辉凯,樊宏伟.反相高效液相色谱法测定洛伐他汀的血浆药物浓度[J].药物分析杂志,1998,18(3):165-167. 被引量:5
  • 2赵飞浪,袁倚盛,沈学英.RP-HPLC测定人血浆中洛伐他汀浓度及药动学研究[J].中国药科大学学报,1997,28(5):288-290. 被引量:12
  • 3陈晓平,黄德嘉,黄明慧,张恒愉,解曼蓉,余叶蓉,胡萍.洛伐他汀对ⅡB型高脂血症患者血脂、血糖及胰岛素代谢的影响[J].华西医科大学学报,1999,30(4):444-445. 被引量:4
  • 4Pearson TA, Mart HJ. The rapid reduction in cardiac events with lipip lowering therapy:mechanisms and implication[J]. Am J Cardial, 1993, 72 : 1072 - 1073. 被引量:1
  • 5Holme I. An analysis of randomized trials evaluating; the effect of cholesterol reduction on total mortality and coronary heart disease indicence[J]. Circulation, 1990, 82:1916 - 1924. 被引量:1
  • 6Bilheime DW. Therapeutic control of hyperlipidemia in the prevention of coronary atherosclerosis: A review of resultls from recent clinical trails[J]. Am J Cardiol, 1988, 62 : 1 - 9. 被引量:1
  • 7Roman K, Ivashkiv E, Arnold ME, et al. Determination of prvasatin Sodium and its major metabolites in human serum/plasma by capillary gas chromatography/negative jon chemical ionization mass spectrometry[J]. Biomedd Environmental Mass Spectrum, 1989,18: 90 - 906. 被引量:1
  • 8Stubbs RJ, Schwartz M, Bayne WF. Determination of mevinolin and mevinolic acid in plasma and bile by reversedphase high performance liquid chromatography[ J ]. Chromatogr Biomed Appl, 1998,383(2):483 - 485. 被引量:1
  • 9Roman K, Vladimir K. Determinition of lovastatin (mevinolin)and mevinolinic acid in fevmentation liquids [J ]. Chromatogr, 1993,630:415 -417. 被引量:1

二级参考文献6

共引文献15

同被引文献12

  • 1Frederick P, Zeller, Karen C. Uvodich lovastatin for hypereholesterolemia [ J ]. Drug Intell Clin Pharm, 1988,22(7,8) :542. 被引量:1
  • 2Bilheime D W. Therapeutic control of hyperlipidemia in the prevention of coronary atherosclerosis: a review of results from recent clinical trails [ J ]. Am J Cardiol, 1988,62 ( 1 ) :1-9. 被引量:1
  • 3Nobilis M,Kopecky J,kvetina J,et al.Comparative biotransfor-mation and disposition studies of nabumetone in humans and minipigs using high-performance liquid chromatography with ultrviolet,fluorscence and mass spectrometric detection[J].J Pharm Biomed Anal,2003,32:641-656. 被引量:1
  • 4Anzenbacherova E,Anzenbacher P,Svoboda Z,et al.Minipig as a model for drug metabolism in man:Comparison of in vitro and in vivo metabolism of propafenone[J].Biomed Papers,2003,147 (2):155-159. 被引量:1
  • 5Pentikainen PJ,Saraheimo M,Schwartz JI,et al.Comparative pharmcokinetics of lovastatin,simvastatin and pravastatin in humans[J].J CAin Pharmacol,1992,32:136-140. 被引量:1
  • 6Reydermanl L,Kosoglou T,Boutrosl T,et al.Pharmaeokinetic interaction between ezetimibe and lovastatin in healthy volunteers[J].Curt Med Res Opin,2004,20:1493-1500. 被引量:1
  • 7Sun JX,Niecestro R,Phillips G.Comparative pharmacokinetics of lovastatin extended-release tablets and lovastatin immediate-release tablets in humans[J].J Clin Pharmacol,2002,42:198-204. 被引量:1
  • 8Halpin RA,Ulm EH,Till AE,et al.Biotransformation of lovastatin:V.Species differences in vivo metabolite profiles of mouse,rat,dog,and human[J].Drug Metab Dispos,1993,21:1003-1011. 被引量:1
  • 9赵飞浪,袁倚盛,沈学英.RP-HPLC测定人血浆中洛伐他汀浓度及药动学研究[J].中国药科大学学报,1997,28(5):288-290. 被引量:12
  • 10陈晓平,黄德嘉,黄明慧,张恒愉,解曼蓉,余叶蓉,胡萍.洛伐他汀对ⅡB型高脂血症患者血脂、血糖及胰岛素代谢的影响[J].华西医科大学学报,1999,30(4):444-445. 被引量:4

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部